Björn F.
- Country
- Germany
- Department
- Innere Medizin, Klinik für Pneumologie
Research Overview
- Phase IIb Randomized, Placebo‑Controlled Study of Oral AZD8965 on Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis
- Efficacy and Safety Evaluation of Buloxibutid in Idiopathic Pulmonary Fibrosis: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
- Phase 3 Randomized Double-Blind Placebo-Controlled Trial Evaluating Intravenous Efzofitimod Efficacy and Safety in Pulmonary Sarcoidosis Patients
Data & Insights
Has run more than one trial at 16 of 92 partner sites.
Specializations
Respiratory Medicine
Specializes in investigating novel therapeutic approaches for pulmonary sarcoidosis, focusing on advanced treatment options for patients with this rare inflammatory condition.
- Inflammatory Lung Disorders
- Interstitial Lung Disease
- Granulomatous Disorders
Actively explores innovative therapeutic interventions using intravenous treatments for respiratory conditions.
Immunology Research
Conducts research in immunological disorders affecting the respiratory system, with particular emphasis on immune-mediated inflammatory conditions.
- Immune System Modulation
- Inflammatory Response
- Autoimmune Conditions
Investigates the therapeutic potential of novel immunomodulatory agents in treating chronic inflammatory diseases.
Clinical Therapeutics
Focuses on evaluating the efficacy and safety of emerging treatments for chronic respiratory conditions through controlled clinical studies.
- Treatment Assessment
- Safety Evaluation
- Patient Outcomes
Specializes in conducting systematic assessments of new therapeutic interventions for respiratory disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.